Thomas H. King

934 total citations
15 papers, 736 citations indexed

About

Thomas H. King is a scholar working on Immunology, Molecular Biology and Plant Science. According to data from OpenAlex, Thomas H. King has authored 15 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Plant Science. Recurrent topics in Thomas H. King's work include RNA modifications and cancer (3 papers), Agronomic Practices and Intercropping Systems (3 papers) and Immunotherapy and Immune Responses (3 papers). Thomas H. King is often cited by papers focused on RNA modifications and cancer (3 papers), Agronomic Practices and Intercropping Systems (3 papers) and Immunotherapy and Immune Responses (3 papers). Thomas H. King collaborates with scholars based in United States, France and Singapore. Thomas H. King's co-authors include Maurille J. Fournier, Ryan R. McCully, Ben Liu, Timothy C. Rodell, Yingnian Lu, David Apelian, Wayne A. Decatur, Édouard Bertrand, Richard C. Duke and Elizabeth S. Maxwell and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Molecular Cell.

In The Last Decade

Thomas H. King

15 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas H. King United States	11	446	136	110	95	76	15	736
Raymond A. Dwek United Kingdom	11	381 0.9×	152 1.1×	57 0.5×	127 1.3×	69 0.9×	11	654
Tsu‐An Hsu Taiwan	16	398 0.9×	140 1.0×	70 0.6×	78 0.8×	26 0.3×	28	804
George H. Yoakum United States	15	400 0.9×	49 0.4×	96 0.9×	183 1.9×	80 1.1×	20	711
Morten Beck Trelle Denmark	16	933 2.1×	153 1.1×	116 1.1×	150 1.6×	79 1.0×	25	1.4k
Bernard Bayard France	20	815 1.8×	224 1.6×	93 0.8×	94 1.0×	36 0.5×	44	1.1k
Elisabeth Narayanan United States	11	501 1.1×	177 1.3×	54 0.5×	138 1.5×	40 0.5×	15	792
Mayuko Nishi Japan	18	587 1.3×	198 1.5×	233 2.1×	102 1.1×	148 1.9×	44	892
Haidi Yin United States	18	572 1.3×	138 1.0×	79 0.7×	72 0.8×	49 0.6×	27	728
Hideo Yoshima Japan	12	743 1.7×	197 1.4×	45 0.4×	87 0.9×	21 0.3×	18	938
Diana Wetmore United States	14	684 1.5×	46 0.3×	111 1.0×	126 1.3×	58 0.8×	20	1.2k

Countries citing papers authored by Thomas H. King

Since Specialization

Citations

This map shows the geographic impact of Thomas H. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas H. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas H. King more than expected).

Fields of papers citing papers by Thomas H. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas H. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas H. King. The network helps show where Thomas H. King may publish in the future.

Co-authorship network of co-authors of Thomas H. King

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas H. King. A scholar is included among the top collaborators of Thomas H. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas H. King. Thomas H. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

King, Thomas H., Crystal A. Shanley, Zhimin Guo, et al.. (2017). GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis. Clinical and Vaccine Immunology. 24(12). 12 indexed citations

Ardiani, Andressa, Sofia R. Gameiro, Claudia Palena, et al.. (2014). Vaccine-Mediated Immunotherapy Directed against a Transcription Factor Driving the Metastatic Process. Cancer Research. 74(7). 1945–1957. 29 indexed citations

King, Thomas H., Zhimin Guo, Yingnian Lu, et al.. (2014). A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral Clearance. PLoS ONE. 9(7). e101904–e101904. 55 indexed citations

Ardiani, Andressa, Benedetto Farsaci, Connie J. Rogers, et al.. (2013). Combination Therapy with a Second-Generation Androgen Receptor Antagonist and a Metastasis Vaccine Improves Survival in a Spontaneous Prostate Cancer Model. Clinical Cancer Research. 19(22). 6205–6218. 71 indexed citations

Madan, Ravi A., Nishith K. Singh, Ann W. Gramza, et al.. (2013). A phase II study of a yeast-based therapeutic cancer vaccine, GI-6207, targeting CEA in patients with minimally symptomatic, metastatic medullary thyroid cancer.. Journal of Clinical Oncology. 31(15_suppl). TPS3127–TPS3127. 5 indexed citations

Liang, Xue‐hai, Qing Liu, Quansheng Liu, Thomas H. King, & Maurille J. Fournier. (2010). Strong dependence between functional domains in a dual-function snoRNA infers coupling of rRNA processing and modification events. Nucleic Acids Research. 38(10). 3376–3387. 18 indexed citations

Haller, Aurelia A., Georg M. Lauer, Thomas H. King, et al.. (2006). Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins. Vaccine. 25(8). 1452–1463. 92 indexed citations

Franzusoff, Alex, Richard C. Duke, Thomas H. King, Yingnian Lu, & Timothy C. Rodell. (2005). Yeasts encoding tumour antigens in cancer immunotherapy. Expert Opinion on Biological Therapy. 5(4). 565–575. 52 indexed citations

King, Thomas H., Ben Liu, Ryan R. McCully, & Maurille J. Fournier. (2003). Ribosome Structure and Activity Are Altered in Cells Lacking snoRNPs that Form Pseudouridines in the Peptidyl Transferase Center. Molecular Cell. 11(2). 425–435. 215 indexed citations

10.

King, Thomas H., et al.. (2003). Antisense and RNAi: powerful tools in drug target discovery and validation.. PubMed. 6(4). 561–9. 41 indexed citations

11.

King, Thomas H., Wayne A. Decatur, Édouard Bertrand, Elizabeth S. Maxwell, & Maurille J. Fournier. (2001). A Well-Connected and Conserved Nucleoplasmic Helicase Is Required for Production of Box C/D and H/ACA snoRNAs and Localization of snoRNP Proteins. Molecular and Cellular Biology. 21(22). 7731–7746. 96 indexed citations

12.

King, Thomas H., Charles K. Mann, & Thomas J. Vickers. (1985). Determination of Phenylpropanolamine Hydrochloride and Acetaminophen in Pharmaceutical Preparations by Raman Spectroscopy. Journal of Pharmaceutical Sciences. 74(4). 443–447. 38 indexed citations

13.

King, Thomas H., et al.. (1981). Minnesota 494-All Pea Germplasm1. HortScience. 16(1). 100–100. 3 indexed citations

14.

King, Thomas H., et al.. (1971). An Evaluation of the Excised Root Tip Method for Determining the Resistance of Pisum sativum to Aphanomyces euteiches1. Journal of the American Society for Horticultural Science. 96(5). 616–619. 4 indexed citations

15.

King, Thomas H., et al.. (1961). Effect of Parasitic Nematodes On the Severity of Common Root Rot of Canning Peas 1). Nematologica. 6(4). 311–314. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact